E-LIB Suche - Ergebnisse für: Vernaz Hegi, N

1

Early specialized care after a first unprovoked epileptic s..:

Fisch, L. ; Lascano, A. M. ; Vernaz Hegi, N....
Journal of Neurology. 263 (2016) 12 - p. 2386-2394 , 2016

Link: https://doi.org/10.1007/..

2

Early specialized care after a first unprovoked epileptic s..:

Fisch, L ; Lascano, A M ; Vernaz Hegi, N...
https://boris.unibe.ch/104844/. , 2016

Link: https://boris.unibe.ch/1..

3

PHP55 CHIRALTY AND HOSPITAL FORMULARY: A SECOND LIFE FOR A ..:

Vernaz-Hegi, N ; Girardin, F ; Muscionico, D..
Value in Health. 11 (2008) 6 - p. A379 , 2008

Link: https://doi.org/10.1016/..

4

PMH18 PRESCRIBING PATTERN OF CITALOPRAM AND ESCITALOPRAM IN..:

Girardin, F ; Vernaz-Hegi, N ; Muscionico, D...
Value in Health. 10 (2007) 6 - p. A292-A293 , 2007

Link: https://doi.org/10.1016/..

5

PDG110 A BUYERS' CLUB TO IMPROVE ACCESS TO HEPATITIS C AND ..:

Vernaz, N. ; Calmy, A. ; Hurst, S....
Value in Health. 22 (2019) - p. S615 , 2019

Link: https://doi.org/10.1016/..

6

How to develop and implement a computerised decision suppor..:

Catho, Gaud ; Waldisphl Suter, Brigitte ; Valotti, R...
Swiss Medical Informatics. , 2019

Link: https://doi.org/10.4414/..

7

Snapshot of Prescribing Practice for Clopidogrel and Esomep..:

Vernaz, N. ; Rollason, V. ; Adlere, L...
Value in Health. 17 (2014) 7 - p. A502 , 2014

Link: https://doi.org/10.1016/..

8

PP060—Patented drug extension strategies and hospital restr..:

Vernaz, N. ; Haller, G. ; Girardin, F....
Clinical Therapeutics. 35 (2013) 8 - p. e35-e36 , 2013

Link: https://doi.org/10.1016/..

9

Agranulocytosis Detection Outcome By Clozapine Treatment (A..:

Girardin, F. ; Poncet, A. ; Blondon, M...
Value in Health. 16 (2013) 7 - p. A725 , 2013

Link: https://doi.org/10.1016/..

10

OC011—Patented Drug Extension Strategies On Health Care Spe..:

Vernaz, N. ; Haller, G. ; Girardin, F....
Clinical Therapeutics. 35 (2013) 8 - p. e5 , 2013

Link: https://doi.org/10.1016/..

11

PP064—Agranulocytosis detection outcome by clozapine treatm..:

Girardin, F.R. ; Poncet, A. ; Blondon, M....
Clinical Therapeutics. 35 (2013) 8 - p. e37-e38 , 2013

Link: https://doi.org/10.1016/..

12

PHP12 Patented Drug Extension Strategies on Health Care Spe..:

Vernaz, N. ; Haller, G. ; Girardin, F....
Value in Health. 15 (2012) 7 - p. A290-A291 , 2012

Link: https://doi.org/10.1016/..

13

Pseudo-innovations : une stratégie payante d'extension des ..:

Vernaz, N. ; Haller, G. ; Girardin, F....
Le Pharmacien Hospitalier et Clinicien. 47 (2012) 1 - p. 61 , 2012

Link: https://doi.org/10.1016/..

14

Effets indésirables des inhibiteurs de la pompe à proton : ..:

Roulet, L. ; Vernaz, N. ; Giostra, E...
La Revue de Médecine Interne. 33 (2012) 8 - p. 439-445 , 2012

Link: https://doi.org/10.1016/..

15

Trends in mupirocin resistance in meticillin-resistant Stap..:

Lee, A.S. ; Macedo-Vinas, M. ; François, P....
Journal of Hospital Infection. 77 (2011) 4 - p. 360-362 , 2011

Link: https://doi.org/10.1016/..